Skip to main content

Grace Wang, Week 4: The Halfway Point

    The past month has really flown by quickly; it's hard to believe that my time in Dr. Mourkioti's lab is already halfway over. I moved into The Radian two days ago (I needed to sublet a new apartment this month because I had previously mixed up my living arrangement), and it's really nice. They even have free drinks in the lobby. The act of moving into a new apartment for the 2nd half of my internship really makes it feel like a new beginning. It helps me come into
     In lab, we've confirmed that NF-kB signaling, which is the pathway I have been studying, gives rise to telomere shortening in the injured control and IKK2ca (in which NF-kB activation is inducible by injury) mice. My lab had previously shown this result, but this time we have more detailed graphs and data. Now that we know there is telomere shortening, as caused by NF-kB signaling, we have to figure out the mechanism of telomere shortening. There are four main possibilities: DNA damage at the telomeres, prolonged muscle stem cell (MuSC) proliferation, epigenetic causes, and RNA damage at the shelterins(these protein complexes "cap" and protect telomeres; they're like telomeres for the telomeres!). We're using different techniques with different markers for each of the aforementioned possibilities: a TIF (Telomere dysfunction Induced Foci) assay makes use of a DNA damage marker called 53BP1, tissue culture techniques are used to quantify MuSC proliferation and to stain MuSCs for the chromatin-modulating protein ATF7, and Q-PCR (similar to PCR) is used to quantify RNA damage by allowing us to analyze the RNA transcripts. We're working on the TIF assay and the tissue culture currently, and we'll do Q-PCR sometime in the near future. Maybe not this week though; our lab gets a break on July 4th and we're also going to eat dim sum on Friday to celebrate my to-be grad student David, who is "graduating" from the lab at the end of the month.
     I'm doing more PCR this week as well to confirm some genotyping for the mice. David will walk us through PCR in detail so we become experts on it. Also, last Friday, I got to watch David and the two undergraduate students working on our neurology project. Specifically, after euthanizing the mice, they dissected them and cut out their gastrocnemius (calf) and tibialis anterior (shin) muscles. I was kind of scared to do it since the tissue removal requires great concentration and surgical precision, but I'll have a chance to do it next time. We fixed them in gel using liquid nitrogen and dry ice. This method, called tissue histology, has very strict protocols because one has to freeze the muscles in a way that the cells won't be damaged when placed in a -80 degree Celsius fridge. After we were done, the undergraduate students dumped the liquid nitrogen into a sink and started playing with the "smoke", which was quite amusing to watch.
     This week, I'm going to practice tissue sectioning, which uses a machine called a cryostat. Essentially, one uses the machine to cut thin slices of the fixed muscle tissue and imprints them on microscope slides. That way, we can analyze them later.
The cryostat machine used to section various types of muscle tissue, anything from large gastrocnemius muscle to tiny Achilles tendons. The inside of the machine has a temperature of between -16 to -24 degrees Celsius.

Comments

Popular posts from this blog

Kylie Heering, Week 2 at the Goldstein Lab

We started off our week with a congratulatory acai bowl trip to celebrate Preston’s acceptance into a training grant program. Acai bowls in California top Playa Bowls (no question about it). From what I can tell, its a pretty huge honor to be recognized by this grant, but he’s really humble about it. On Monday, Preston and I decided that testing antibodies that have never been tested on prostate epithelial cells before would be a good objective for my first Western blot on my own. We needed to probe for ASCT2, a glutamine transporter, and GLS in order to determine if their corresponding antibodies are functional. Antibodies are crucial for Western blots because they bind to the protein of interest (POI), allowing for us to qualify its expression after imaging. As such, Preston wanted to make sure they worked by probing for ASCT2 and GLS on three different cell lines. Cell lines are commercially purchased human cells that have been immortalized (modified to grow indefinitely) by telome...

Alan - First Week at UCSF

Hi Everyone! After arriving in San Francisco last Sunday, I spent this past week settling into the downtown Berkeley apartment that I’ll be sharing with Rohit for the next couple of months, as well as learning my way around the Roy lab at UCSF. First day at the lab was really exciting. Here are a couple pictures of the Mission Bay campus, which was completed just a few years ago. Everything is super new and modern, and there’s still construction for other buildings going on around the campus. Most of the people who work at the Mission Bay campus are either professional researchers or doctors/nurses for the nearby hospital. The graduate students take most of their classes at the original Parnassus campus (where Maya is). I work in Byers Hall, which is connected to Genentech Hall and a short walk down the block from the shuttle stop. There are three other volunteers working for the Roy lab this summer – Kimmai, David, and Pujita, who are all undergrad college students...

Jaewon Oh - Week 7 and 8

Finally done here with my experience and I wish I had more time keep researching so that I have something a little more "finalised" to present. But I guess that's what past EXP kids meant when they said that 8 weeks of research is not enough and I'll have to work with what I've got. To solve the problem of not having enough data points, we used the online TCGA database for raw data that would be used to calculate mutation rates. Mutation rates were calculated through an R coding script that Dr. Cannataro had made. Because the mutation rates were tumor specific, we had to change the proportions that were obtained from the IARC database using data from another database called cBioPortal. Basically we had to multiply the number of times a certain variant was seen in the IARC database by the percentage of tumors that have a tp53 mutation, because our mutation rates are calculated across all tumors in specific cancers (confusing, I know). After graphing the mutatio...